[go: up one dir, main page]

WO2002010366A3 - Methods and compositions for diagnosing and treating chromosome-18p related disorders - Google Patents

Methods and compositions for diagnosing and treating chromosome-18p related disorders Download PDF

Info

Publication number
WO2002010366A3
WO2002010366A3 PCT/US2001/024417 US0124417W WO0210366A3 WO 2002010366 A3 WO2002010366 A3 WO 2002010366A3 US 0124417 W US0124417 W US 0124417W WO 0210366 A3 WO0210366 A3 WO 0210366A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
diagnosing
compositions
related disorders
disorder
Prior art date
Application number
PCT/US2001/024417
Other languages
French (fr)
Other versions
WO2002010366A2 (en
Inventor
Hong Chen
Nelson B Freimer
Thomas Novak
Original Assignee
Millennium Pharm Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc, Univ California filed Critical Millennium Pharm Inc
Priority to CA002417703A priority Critical patent/CA2417703A1/en
Priority to IL15423901A priority patent/IL154239A0/en
Priority to EP01959489A priority patent/EP1307549A2/en
Priority to AU2001281041A priority patent/AU2001281041A1/en
Publication of WO2002010366A2 publication Critical patent/WO2002010366A2/en
Publication of WO2002010366A3 publication Critical patent/WO2002010366A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to the mammalian HKNG1, GNKH and TS genes, genes associated with bipolar affective disorder (BAD) in humans. The invention relates, in particular, to methods for the diagnostic evaluation, genetic testing and prognosis of HKNG1, GNKH, and TS neuropsychiatric disorders including schizophrenia, attention deficit disorder, a schizoaffective disorder, a bipolar affective disorder or a unipolar affective disorder.
PCT/US2001/024417 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders WO2002010366A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002417703A CA2417703A1 (en) 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders
IL15423901A IL154239A0 (en) 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders
EP01959489A EP1307549A2 (en) 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders
AU2001281041A AU2001281041A1 (en) 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63127500A 2000-08-02 2000-08-02
US09/631,275 2000-08-02
US72254400A 2000-11-28 2000-11-28
US09/722,544 2000-11-28

Publications (2)

Publication Number Publication Date
WO2002010366A2 WO2002010366A2 (en) 2002-02-07
WO2002010366A3 true WO2002010366A3 (en) 2002-08-29

Family

ID=27091342

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/024417 WO2002010366A2 (en) 2000-08-02 2001-08-02 Methods and compositions for diagnosing and treating chromosome-18p related disorders

Country Status (5)

Country Link
EP (1) EP1307549A2 (en)
AU (1) AU2001281041A1 (en)
CA (1) CA2417703A1 (en)
IL (1) IL154239A0 (en)
WO (1) WO2002010366A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114250224B (en) * 2021-12-16 2024-02-27 福建和瑞基因科技有限公司 Nucleic acid composition for extracting or detecting small-molecule RNA in sample, kit and method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047535A1 (en) * 1998-03-16 1999-09-23 Millennium Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047535A1 (en) * 1998-03-16 1999-09-23 Millennium Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROJAS K ET AL: "Identification of candidate genes for psychiatric disorders on 18p11.", MOLECULAR PSYCHIATRY, vol. 5, no. 4, July 2000 (2000-07-01), pages 389 - 395, XP001061966, ISSN: 1359-4184 *
YOSHIKAWA T ET AL: "ISOLATION OF CHROMOSOME 18-SPECIFIC BRAIN TRANSCRIPTS AS POSITIONALCANDIDATES FOR BIPOLAR DISORDER", AMERICAN JOURNAL OF MEDICAL GENETICS, NEW YORK,NY, US, vol. 74, no. 2, 18 April 1997 (1997-04-18), pages 140 - 149, XP001008133 *

Also Published As

Publication number Publication date
CA2417703A1 (en) 2002-02-07
IL154239A0 (en) 2003-07-31
EP1307549A2 (en) 2003-05-07
AU2001281041A1 (en) 2002-02-13
WO2002010366A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
GB2342717A (en) Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
WO2003071927A3 (en) Diagnostics and therapeutics for macular degeneration-related disorders
MXPA03002413A (en) B7-like molecules and uses thereof.
CY1113145T1 (en) Molecular Recipients of Thymic Stratified Lymphopoietin and Their Uses
ATE269402T1 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
ATE289200T1 (en) OLIGONUCLEOTIDE COMPOSITION AND METHOD FOR REGULATING PROTEIN B7 EXPRESSION
ATE194391T1 (en) AMPLIFICATION OLIGONUCLEOTIDES AND PROBE FOR BORRELIA ASSOCIATED WITH LYME DISEASE
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2001061007A3 (en) Fibroblast growth factor-23 molecules and uses thereof
EP1163515A4 (en) DIAGNOSTIC AND THERAPEUTIC TOOLS FOR TREATING NUCLEAR TOLERANCE DISORDERS
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
DE60109430D1 (en) GENES INVOLVED IN INFLAMMATORY ENDURANCE AND THEIR USE
WO2007081608A3 (en) Novel gene disruptions, compositions and methods relating thereto
WO2004026107A3 (en) Kits and methods for assessing skin health
EP0630973A3 (en) Diagnostic compositions, elements, methods & test kits for amplification & detection of two or more DNA's using primers having matched melting temperatures.
DE69816467D1 (en) ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVELY IN NERVOUS LINE
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
WO1999051186A3 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
SE9503117D0 (en) Novel use of padlock probes
CA2112096A1 (en) Dna sequences of the human papillomavirus type 42 and diagnostic application thereof
WO2002010366A3 (en) Methods and compositions for diagnosing and treating chromosome-18p related disorders
MXPA02000680A (en) Vgf polypeptides and methods of treating vgf-related disorders.
WO2003038130A3 (en) Therapeutics and diagnostics for disorders of erythropoiesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2417703

Country of ref document: CA

Ref document number: 2001281041

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 154239

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001959489

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001959489

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001959489

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP